nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Raltegravir

DRESS syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Thomas M, et al. The HLA-B*53 / HLA-C*04 haplotype is strongly associated with dress syndrome during treatment with raltegravir. Open Forum Infectious Diseases 3 (Suppl. 1): no pagination (plus poster) abstr. 1510, 25 Oct 2016. Available from: URL: http://doi.org/10.1093/ofid/ofw172.1212 [abstract] - New Zealand

Titel: Raltegravir
DRESS syndrome: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63847-0

Amiodarone/itraconazole interaction

Case report

Paracetamol overdose

Case report

Cefuroxime/ibuprofen

Case report

Dexamethasone/temozolomide

Case report

Quetiapine/topiramate interaction

Case report

Revusiran

Case report

Springer Medizin

Raltegravir

DRESS syndrome: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Amiodarone/itraconazole interaction

Paracetamol overdose

Cefuroxime/ibuprofen

Dexamethasone/temozolomide

Quetiapine/topiramate interaction

Revusiran

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Amiodarone/itraconazole interaction

Paracetamol overdose

Cefuroxime/ibuprofen

Dexamethasone/temozolomide

Quetiapine/topiramate interaction

Revusiran